The triple helix of collagens – an ancient protein structure that enabled animal multicellularity and tissue evolution
暂无分享,去创建一个
[1] D. Germain,et al. Vascular Ehlers-Danlos syndrome , 2020, Definitions.
[2] R. Lennon,et al. Basement Membrane Defects in Genetic Kidney Diseases , 2018, Front. Pediatr..
[3] H. Philippe,et al. Improved Modeling of Compositional Heterogeneity Supports Sponges as Sister to All Other Animals , 2017, Current Biology.
[4] A. Rokas,et al. Embracing Uncertainty in Reconstructing Early Animal Evolution , 2017, Current Biology.
[5] Allison L. Zajac,et al. Tissue Structure: A CIVICs Lesson for Adipocytes , 2017, Current Biology.
[6] J. C. Pastor-Pareja,et al. Inter-adipocyte Adhesion and Signaling by Collagen IV Intercellular Concentrations in Drosophila , 2017, Current Biology.
[7] B. Hudson,et al. Building collagen IV smart scaffolds on the outside of cells , 2017, Protein science : a publication of the Protein Society.
[8] I. Ruiz-Trillo,et al. Dynamics of genomic innovation in the unicellular ancestry of animals , 2017, eLife.
[9] A. Rokas,et al. Collagen IV and basement membrane at the evolutionary dawn of metazoan tissues , 2017, eLife.
[10] Ranjay Jayadev,et al. Basement membranes , 2017, Current Biology.
[11] Brendan H. Lee,et al. P3h3-null and Sc65-null Mice Phenocopy the Collagen Lysine Under-hydroxylation and Cross-linking Abnormality of Ehlers-Danlos Syndrome Type VIA* , 2017, The Journal of Biological Chemistry.
[12] C. Kashtan. Alport syndrome: facts and opinions , 2017, F1000Research.
[13] B. Hudson,et al. Lysyl Oxidase-like-2 Cross-links Collagen IV of Glomerular Basement Membrane* , 2016, The Journal of Biological Chemistry.
[14] K. Masuda,et al. A novel missense mutation of COL5A2 in a patient with Ehlers–Danlos syndrome , 2016, Human Genome Variation.
[15] A. Pozzi,et al. Extracellular chloride signals collagen IV network assembly during basement membrane formation , 2016, The Journal of cell biology.
[16] M. Telford,et al. Evolution: A sisterly dispute , 2016, Nature.
[17] A. Fabre,et al. Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies , 2016, Human mutation.
[18] H. Philippe,et al. Genomic data do not support comb jellies as the sister group to all other animals , 2015, Proceedings of the National Academy of Sciences.
[19] C. Logan,et al. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain , 2015, American journal of human genetics.
[20] P. Byers. Vascular Ehlers-Danlos Syndrome , 2015 .
[21] R. Pauli,et al. Novel COL2A1 Variant (c.619G>A, p.Gly207Arg) Manifesting as a Phenotype Similar to Progressive Pseudorheumatoid Dysplasia and Spondyloepiphyseal Dysplasia, Stanescu Type , 2015, Human mutation.
[22] D. Sherwood. A developmental biologist’s “outside-the-cell” thinking , 2015, The Journal of cell biology.
[23] Ferris M. Pfeiffer,et al. Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype. , 2015, The American journal of pathology.
[24] S. Shinkuma. Dystrophic epidermolysis bullosa: a review , 2015, Clinical, cosmetic and investigational dermatology.
[25] L. Moroz,et al. Error, signal, and the placement of Ctenophora sister to all other animals , 2015, Proceedings of the National Academy of Sciences.
[26] B. Olsen,et al. Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications , 2015, Journal of Translational Medicine.
[27] Therese G. Kellgren,et al. Mutations in Collagen, Type XVII, Alpha 1 (COL17A1) Cause Epithelial Recurrent Erosion Dystrophy (ERED) , 2015, Human mutation.
[28] M. Bissell,et al. Mammary gland development: cell fate specification, stem cells and the microenvironment , 2015, Development.
[29] M. Tekin,et al. Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53 , 2015, Molecular Genetics and Genomics.
[30] Kristie L. Rose,et al. Hypohalous Acids Contribute to Renal Extracellular Matrix Damage in Experimental Diabetes , 2015, Diabetes.
[31] A. Alaiya,et al. Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder. , 2015, American journal of human genetics.
[32] Z. Werb,et al. Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.
[33] Jongsun Jung,et al. Novel COL9A3 mutation in a family diagnosed with multiple epiphyseal dysplasia: a case report , 2014, BMC Musculoskeletal Disorders.
[34] J. Zenteno,et al. Erratum to: Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosity , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.
[35] J. Lupski,et al. Mutations in COL27A1 cause Steel syndrome and suggest a founder mutation effect in the Puerto Rican population , 2014, European Journal of Human Genetics.
[36] B. Hudson,et al. Bromine Is an Essential Trace Element for Assembly of Collagen IV Scaffolds in Tissue Development and Architecture , 2014, Cell.
[37] Victor V. Solovyev,et al. The Ctenophore Genome and the Evolutionary Origins of Neural Systems , 2014, Nature.
[38] M. Devoto,et al. Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice. , 2014, Human molecular genetics.
[39] K. Bushby,et al. Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. , 2014, Human molecular genetics.
[40] T. Iwatsubo,et al. CLAC-P/Collagen Type XXV Is Required for the Intramuscular Innervation of Motoneurons during Neuromuscular Development , 2014, The Journal of Neuroscience.
[41] Kristie L. Rose,et al. A unique covalent bond in basement membrane is a primordial innovation for tissue evolution , 2013, Proceedings of the National Academy of Sciences.
[42] Nicholas H. Putnam,et al. The Genome of the Ctenophore Mnemiopsis leidyi and Its Implications for Cell Type Evolution , 2013, Science.
[43] D. Richter,et al. The genomic and cellular foundations of animal origins. , 2013, Annual review of genetics.
[44] Kenneth M. Yamada,et al. ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. , 2013, Current opinion in genetics & development.
[45] K. Okuyama,et al. Posttranslational Modifications in Type I Collagen from Different Tissues Extracted from Wild Type and Prolyl 3-Hydroxylase 1 Null Mice* , 2013, The Journal of Biological Chemistry.
[46] M. Sternberg,et al. Polyproline-II helix in proteins: structure and function. , 2013, Journal of molecular biology.
[47] Thomas Haaf,et al. Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6 , 2013, European Journal of Human Genetics.
[48] F. Alkuraya,et al. No evidence for locus heterogeneity in Knobloch syndrome , 2013, Journal of Medical Genetics.
[49] K. Natsuga. Epidermolysis bullosa simplex , 2013, Der Hautarzt.
[50] Paul H. Huang,et al. Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling* , 2013, The Journal of Biological Chemistry.
[51] K. Yokochi,et al. Phenotypic Spectrum of COL4A1 Mutations: Porencephaly to Schizencephaly , 2013, Annals of neurology.
[52] B. Hudson,et al. Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. , 2012, Nature chemical biology.
[53] S. Ellard,et al. Childhood presentation of COL4A1 mutations , 2012, Developmental medicine and child neurology.
[54] S. Greenberg,et al. COL4A1 mutations in patients with sporadic late‐onset intracerebral hemorrhage , 2012, Annals of neurology.
[55] K. Tasanen,et al. Transmembrane collagen XVII is a novel component of the glomerular filtration barrier , 2012, Cell and Tissue Research.
[56] R. Hynes. The evolution of metazoan extracellular matrix , 2012, The Journal of cell biology.
[57] Celina G. Kleer,et al. Discoidin domain receptor tyrosine kinases: new players in cancer progression , 2012, Cancer and Metastasis Reviews.
[58] L. Ala‐Kokko,et al. Dominant and recessive forms of fibrochondrogenesis resulting from mutations at a second locus, COL11A2 , 2012, American journal of medical genetics. Part A.
[59] B. Degnan,et al. Origin and evolution of laminin gene family diversity. , 2012, Molecular biology and evolution.
[60] S. Greenberg,et al. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. , 2012, American journal of human genetics.
[61] K. Yokochi,et al. De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly. , 2012, American journal of human genetics.
[62] R. Boot-Handford,et al. Collagen XXVII Organises the Pericellular Matrix in the Growth Plate , 2011, PloS one.
[63] M. Thomassen,et al. Clinical utility gene card for: Alport syndrome , 2011, European Journal of Human Genetics.
[64] P. Bauer,et al. Discrepancies in reporting the CAG repeat lengths for Huntington's disease , 2011, European Journal of Human Genetics.
[65] D. O’Rielly,et al. Avascular necrosis of the femoral head due to a novel C propeptide mutation in COL2A1 , 2011, American journal of medical genetics. Part A.
[66] L. Ala‐Kokko,et al. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome , 2011, American journal of medical genetics. Part A.
[67] Joan C. Marini,et al. New perspectives on osteogenesis imperfecta , 2011, Nature Reviews Endocrinology.
[68] K. Jepsen,et al. Type XII collagen regulates osteoblast polarity and communication during bone formation , 2011, The Journal of cell biology.
[69] P. Yurchenco. Basement membranes: cell scaffoldings and signaling platforms. , 2011, Cold Spring Harbor perspectives in biology.
[70] J. Orgel,et al. Molecular and structural mapping of collagen fibril interactions , 2011, Connective tissue research.
[71] Shane T. Jensen,et al. Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes , 2011, Human mutation.
[72] D. Eyre,et al. A Novel 3-Hydroxyproline (3Hyp)-rich Motif Marks the Triple-helical C Terminus of Tendon Type I Collagen* , 2011, The Journal of Biological Chemistry.
[73] Josephine C. Adams,et al. The Evolution of Extracellular Matrix , 2010, Molecular biology of the cell.
[74] N. King,et al. Diverse evolutionary paths to cell adhesion. , 2010, Trends in cell biology.
[75] Michael F. Wangler,et al. Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene. , 2010, American journal of human genetics.
[76] Lee B. Smith,et al. Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers–Danlos syndrome , 2010, Cardiovascular research.
[77] S. Young,et al. Deletion of the Basement Membrane Heparan Sulfate Proteoglycan Type XVIII Collagen Causes Hypertriglyceridemia in Mice and Humans , 2010, PloS one.
[78] B. Degnan,et al. Origin of animal epithelia: insights from the sponge genome , 2010, Evolution & development.
[79] F. Gekeler,et al. Novel COL4A1 mutations associated with HANAC syndrome: A role for the triple helical CB3[IV] domain , 2010, American journal of medical genetics. Part A.
[80] R. Kalluri,et al. Identification of the NC1 Domain of α3 Chain as Critical for α3α4α5 Type IV Collagen Network Assembly , 2010, The Journal of Biological Chemistry.
[81] P. Tam,et al. Loss of procollagen IIA from the anterior mesendoderm disrupts the development of mouse embryonic forebrain , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.
[82] E. Neilson,et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. , 2010, The New England journal of medicine.
[83] Howard Martin,et al. Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1 , 2010, Human mutation.
[84] C. Cluzel,et al. The Fibrillar Collagen Family , 2010, International journal of molecular sciences.
[85] R. Hynes. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[86] G. Nishimura,et al. Czech dysplasia occurring in a Japanese family , 2009, American journal of medical genetics. Part A.
[87] T. Veenstra,et al. A Sulfilimine Bond Identified in Collagen IV , 2009, Science.
[88] S. Leys,et al. Epithelia and integration in sponges. , 2009, Integrative and comparative biology.
[89] Ronald T Raines,et al. Collagen structure and stability. , 2009, Annual review of biochemistry.
[90] Frauke Meyer,et al. Drosophila multiplexin (Dmp) modulates motor axon pathfinding accuracy , 2009, Development, growth & differentiation.
[91] A. De Paepe,et al. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers‐Danlos syndrome , 2009, Human mutation.
[92] B. Schierwater,et al. Placozoa and the evolution of Metazoa and intrasomatic cell differentiation. , 2009, The international journal of biochemistry & cell biology.
[93] L. D. de Vries,et al. COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage , 2009, Annals of neurology.
[94] Hilary L. Ashe,et al. Type IV collagens regulate BMP signalling in Drosophila , 2008, Nature.
[95] S. Mundlos,et al. Czech dysplasia: Report of a large family and further delineation of the phenotype , 2008, American journal of medical genetics. Part A.
[96] B. Hudson,et al. Mammalian collagen IV , 2008, Microscopy research and technique.
[97] Nicholas H. Putnam,et al. The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans , 2008, Nature.
[98] L. Ala‐Kokko,et al. Missense and nonsense mutations in the alternatively‐spliced exon 2 of COL2A1 cause the ocular variant of Stickler syndrome , 2008, Human mutation.
[99] T. Desmettre,et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. , 2007, The New England journal of medicine.
[100] B. Ceulemans,et al. Molecular consequences of dominant Bethlem myopathy collagen VI mutations , 2007, Annals of neurology.
[101] I. Nonaka,et al. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease , 2007, Neurology.
[102] J. Orgogozo,et al. COL4A1 mutation in Axenfeld–Rieger anomaly with leukoencephalopathy and stroke , 2007, Annals of neurology.
[103] Clair Baldock,et al. Collagens at a glance , 2007, Journal of Cell Science.
[104] P. Thorner. Alport Syndrome and Thin Basement Membrane Nephropathy , 2007, Nephron Clinical Practice.
[105] J. Sanes,et al. Distinct Target-Derived Signals Organize Formation, Maturation, and Maintenance of Motor Nerve Terminals , 2007, Cell.
[106] R. Kalluri,et al. Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. , 2007, Kidney international.
[107] H. Ohashi,et al. A recurrent mutation in type II collagen gene causes Legg-Calvé-Perthes disease in a Japanese family , 2007, Human Genetics.
[108] F. Glorieux,et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.
[109] B. Hudson,et al. Molecular Recognition in the Assembly of Collagens: Terminal Noncollagenous Domains Are Key Recognition Modules in the Formation of Triple Helical Protomers* , 2006, Journal of Biological Chemistry.
[110] G. Deléage,et al. Insights into early extracellular matrix evolution: spongin short chain collagen-related proteins are homologous to basement membrane type IV collagens and form a novel family widely distributed in invertebrates. , 2006, Molecular biology and evolution.
[111] Robert D Burke,et al. The echinoderm adhesome. , 2006, Developmental biology.
[112] J. van den Ende,et al. A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. , 2006, American journal of human genetics.
[113] J. Sundberg,et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. , 2006, The New England journal of medicine.
[114] M. Bissell,et al. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.
[115] A. Aszódi,et al. Type IX collagen is crucial for normal hearing , 2005, Neuroscience.
[116] A. De Paepe,et al. Total absence of the α2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems , 2005, Journal of Medical Genetics.
[117] E. Bertini,et al. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy , 2005, Annals of neurology.
[118] A. Latos-Bieleńska,et al. Novel amino acid substitution in the Y‐position of collagen type II causes spondyloepimetaphyseal dysplasia congenita , 2005, American journal of medical genetics. Part A.
[119] S. Ricard-Blum,et al. The collagen superfamily: from the extracellular matrix to the cell membrane. , 2005, Pathologie-biologie.
[120] W. Arts,et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly , 2005, Journal of Medical Genetics.
[121] Y. Riazalhosseini,et al. Mutation of COL11A2 causes autosomal recessive non-syndromic hearing loss at the DFNB53 locus , 2005, Journal of Medical Genetics.
[122] O. Gross,et al. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome , 2005, Human mutation.
[123] E. Bertini,et al. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy , 2005, Neurology.
[124] Ling-Hui Li,et al. Type II collagen gene variants and inherited osteonecrosis of the femoral head. , 2005, The New England journal of medicine.
[125] R. Savarirayan,et al. Mutations of COL10A1 in Schmid metaphyseal chondrodysplasia , 2005, Human mutation.
[126] P. Heutink,et al. Mutations in Col4a1 Cause Perinatal Cerebral Hemorrhage and Porencephaly , 2005, Science.
[127] G. Mortier,et al. Dominant negative mutations in the C‐propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies , 2005, American journal of medical genetics. Part A.
[128] K. Bushby,et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Journal of Medical Genetics.
[129] A. De Paepe,et al. The molecular basis of classic Ehlers‐Danlos syndrome: A comprehensive study of biochemical and molecular findings in 48 unrelated patients , 2005, Human mutation.
[130] D. Sillence,et al. 108 A NOVEL COL1A1 MUTATION IN INFANTILE CORTICAL HYPEROSTOSIS (CAFFEY DISEASE) EXPANDS THE SPECTRUM OF COLLAGEN-RELATED DISORDERS , 2005, Journal of Investigative Medicine.
[131] I. Chervoneva,et al. Type V Collagen Controls the Initiation of Collagen Fibril Assembly* , 2004, Journal of Biological Chemistry.
[132] K. North,et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. , 2004, Human molecular genetics.
[133] B. Hudson,et al. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. , 2004, Journal of the American Society of Nephrology : JASN.
[134] R. Kauppinen,et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. , 2004, Human molecular genetics.
[135] S. Rattan,et al. Esophageal muscle physiology and morphogenesis require assembly of a collagen XIX–rich basement membrane zone , 2004, The Journal of cell biology.
[136] Wei Li,et al. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa , 2004, Nature Medicine.
[137] U. Schlötzer-Schrehardt,et al. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development , 2004, Development.
[138] C. Kashtan. Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy , 2004, Current opinion in pediatrics.
[139] R. Kosaki,et al. Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type , 2004, Journal of Medical Genetics.
[140] K. Tryggvason,et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. , 2003, The New England journal of medicine.
[141] R. Cotton,et al. Mutations in the COL4A4 gene in thin basement membrane disease. , 2003, Kidney international.
[142] R. Boot-Handford,et al. Fibrillar collagen: The key to vertebrate evolution? A tale of molecular incest , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[143] M. Raghunath,et al. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome. , 2002, American journal of medical genetics.
[144] C. Antignac,et al. Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria. , 2002, Journal of the American Society of Nephrology : JASN.
[145] N. Fukai,et al. Lack of collagen XVIII/endostatin results in eye abnormalities , 2002, The EMBO journal.
[146] Yan Wu,et al. A novel homozygous point mutation in the COL17A1 gene in a Chinese family with generalized atrophic benign epidermolysis bullosa. , 2002, Journal of dermatological science.
[147] Nimish J. Thakore,et al. Novel mutations in collagen VI genes: Expansion of the Bethlem myopathy phenotype , 2002, Neurology.
[148] Shawn M. Sweeney,et al. Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen* , 2002, The Journal of Biological Chemistry.
[149] T. Spector,et al. A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. , 2001, American journal of human genetics.
[150] V. Sheffield,et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. , 2001, Human molecular genetics.
[151] T. Pihlajaniemi,et al. Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy. , 2001, The American journal of pathology.
[152] J. Ott,et al. Identification of a novel common genetic risk factor for lumbar disk disease. , 2001, JAMA.
[153] L Eklund,et al. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[154] H. Smeets,et al. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. , 2000, Kidney international.
[155] P. Harper,et al. Variation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helix. , 2000, American journal of human genetics.
[156] A. Camargo,et al. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). , 2000, Human molecular genetics.
[157] K. Tasanen,et al. Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain. , 2000, The Journal of investigative dermatology.
[158] L. Ala‐Kokko,et al. Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis. , 2000, American journal of medical genetics.
[159] G. Mortier,et al. Report of five novel and one recurrentCOL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder , 2000, Journal of medical genetics.
[160] L. Lagae,et al. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. , 2000, American journal of human genetics.
[161] Richard W. Farndale,et al. Structural Basis of Collagen Recognition by Integrin α2β1 , 2000, Cell.
[162] K. Tasanen,et al. Collagen XVII Is Destabilized by a Glycine Substitution Mutation in the Cell Adhesion Domain Col15* , 2000, The Journal of Biological Chemistry.
[163] R. Hennekam,et al. Autosomal recessive disorder otospondylomegaepiphyseal dysplasia is associated with loss-of-function mutations in the COL11A2 gene. , 2000, American journal of human genetics.
[164] C. Giunta,et al. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability? , 2000, American journal of medical genetics.
[165] M. King,et al. Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13) , 1999, Nature Genetics.
[166] B. Olsen,et al. A short isoform of Col9a1 supports alveolar bone repair. , 1999, The American journal of pathology.
[167] J. Uitto,et al. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. , 1999, Journal of cell science.
[168] D J Prockop,et al. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. , 1999, American journal of human genetics.
[169] J. Ott,et al. An allele of COL9A2 associated with intervertebral disc disease. , 1999, Science.
[170] G. Mortier,et al. Identification of novel pro-alpha2(IX) collagen gene mutations in two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia. , 1999, American journal of human genetics.
[171] E. Bertini,et al. A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagen , 1999, Neuromuscular Disorders.
[172] F. Revert,et al. Characterization of a Novel Type of Serine/Threonine Kinase That Specifically Phosphorylates the Human Goodpasture Antigen* , 1999, The Journal of Biological Chemistry.
[173] L. Ala‐Kokko,et al. COL9A3: A third locus for multiple epiphyseal dysplasia. , 1999, American journal of human genetics.
[174] K. Campbell,et al. A Role for Dystroglycan in Basement Membrane Assembly , 1998, Cell.
[175] P. Braghetta,et al. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. , 1998, Human molecular genetics.
[176] L. Ala‐Kokko,et al. Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymüller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome). , 1998, American journal of medical genetics.
[177] Z. Werb,et al. ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.
[178] G. Mollet,et al. Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. , 1998, American journal of human genetics.
[179] N. Burrows,et al. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II. , 1998, Journal of medical genetics.
[180] Guy Riddihough,et al. Structure of collagen , 1998, Nature Structural Biology.
[181] M. Yamauchi,et al. Altered posttranslational modifications of collagen in keloid. , 1998, Biochemical and biophysical research communications.
[182] J. McGee,et al. Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome , 1998, Hearing Research.
[183] M. Pericak-Vance,et al. Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy. , 1998, Human molecular genetics.
[184] K. Michalickova,et al. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. , 1998, Human molecular genetics.
[185] M. Warman,et al. Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen. , 1998, The Journal of pediatrics.
[186] J. Uitto,et al. Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa. , 1997, American journal of human genetics.
[187] J. Uitto,et al. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa. , 1997, The Journal of investigative dermatology.
[188] J. Naeyaert,et al. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. , 1997, American journal of human genetics.
[189] D. Meehan,et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. , 1996, Genes & development.
[190] F. Baas,et al. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures , 1996, Nature Genetics.
[191] J. Yates,et al. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. , 1996, Human molecular genetics.
[192] H. Smeets,et al. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene. , 1996, The Journal of clinical investigation.
[193] A. Winterpacht,et al. The deletion of six amino acids at the C-terminus of the alpha 1 (II) chain causes overmodification of type II and type XI collagen: further evidence for the association between small deletions in COL2A1 and Kniest dysplasia. , 1996, Journal of medical genetics.
[194] J. R. McMillan,et al. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. , 1996, The American journal of pathology.
[195] J. Uitto,et al. Influence of the second COL7A1 mutation in determining the phenotypic severity of recessive dystrophic epidermolysis bullosa. , 1996, The Journal of investigative dermatology.
[196] H. Helminen,et al. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. , 1995, Genes & development.
[197] D. Rimoin,et al. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type , 1995, Nature Genetics.
[198] M. Plana,et al. Phosphorylation of the Goodpasture Antigen by Type A Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[199] F. Revert,et al. Characterization and expression of multiple alternatively spliced transcripts of the Goodpasture antigen gene region. Goodpasture antibodies recognize recombinant proteins representing the autoantigen and one of its alternative forms. , 1995, European journal of biochemistry.
[200] F. Revert,et al. Characterization and Expression of Multiple Alternatively Spliced Transcripts of the Goodpasture Antigen Gene Region , 1995 .
[201] N. Morris,et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis , 1995, Cell.
[202] K. Cheah,et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus , 1995, Cell.
[203] D. Wilkin,et al. A radiographic, morphologic, biochemical and molecular analysis of a case of achondrogenesis type II resulting from substitution for a glycine residue (Gly691-->Arg) in the type II collagen trimer. , 1995, Human molecular genetics.
[204] S. Mundlos,et al. A COL2A1 Mutation in Achondrogenesis Type II Results in the Replacement of Type II Collagen by Type I and III Collagens in Cartilage (*) , 1995, The Journal of Biological Chemistry.
[205] D. Rimoin,et al. A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia. , 1994, Human molecular genetics.
[206] H M Berman,et al. Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. , 1994, Science.
[207] P. Narcisi,et al. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen. , 1994, Human molecular genetics.
[208] R. Behringer,et al. Normal long bone growth and development in type X collagen-null mice , 1994, Nature Genetics.
[209] C. David,et al. Fibrous Mini-Collagens in Hydra Nematocysts , 1994, Science.
[210] P. Schnegelsberg,et al. Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[211] J. Uitto,et al. Dominant dystrophic epidermolysis bullosa: identification of a Gly-->Ser substitution in the triple-helical domain of type VII collagen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[212] J. T. Thomas,et al. Amino acid substitutions of conserved residues in the carboxyl-terminal domain of the alpha 1(X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid. , 1994, American journal of human genetics.
[213] B. Olsen,et al. Additional mutations of type X collagen confirm COL10A1 as the Schmid metaphyseal chondrodysplasia locus. , 1994, Human molecular genetics.
[214] R. Golbik,et al. The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). , 1993, The EMBO journal.
[215] S. Jimenez,et al. Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family with an Arg75→Cys mutation in the procollagen type II gene (COL2A1) , 1993, Human Genetics.
[216] W. Cole,et al. Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. , 1993, The Journal of biological chemistry.
[217] L. Ala‐Kokko,et al. Mutation in type II procollagen (COL2A1) that substitutes aspartate for glycine alpha 1-67 and that causes cataracts and retinal detachment: evidence for molecular heterogeneity in the Wagner syndrome and the Stickler syndrome (arthro-ophthalmopathy) , 1993, American journal of human genetics.
[218] H. Dietz,et al. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa , 1993, Nature Genetics.
[219] M. Bissell,et al. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[220] C. Antignac,et al. Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. , 1992, American journal of human genetics.
[221] K. Tryggvason,et al. Complete amino acid sequence of the human alpha 5 (IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. , 1992, The Journal of biological chemistry.
[222] G. Rizzoni,et al. De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome. , 1992, Human molecular genetics.
[223] J. Exposito,et al. Short chain collagens in sponges are encoded by a family of closely related genes. , 1991, The Journal of biological chemistry.
[224] D. Higgins,et al. The NC1 domain of type IV collagen promotes axonal growth in sympathetic neurons through interaction with the alpha 1 beta 1 integrin , 1991, The Journal of cell biology.
[225] R. Moskowitz,et al. Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[226] M. Skolnick,et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. , 1990, Science.
[227] D. Rimoin,et al. Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[228] H. Kuivaniemi,et al. Single base mutation in the type III procollagen gene that converts the codon for glycine 883 to aspartate in a mild variant of Ehlers-Danlos syndrome IV. , 1989, The Journal of biological chemistry.
[229] H. Vissing,et al. Glycine to serine substitution in the triple helical domain of pro-alpha 1 (II) collagen results in a lethal perinatal form of short-limbed dwarfism. , 1989, The Journal of biological chemistry.
[230] W. Cole,et al. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta. , 1989, The Journal of biological chemistry.
[231] D. Rogers,et al. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. , 1989, Science.
[232] J. Fine,et al. Epidermolysis bullosa simplex superficialis. A new variant of epidermolysis bullosa characterized by subcorneal skin cleavage mimicking peeling skin syndrome. , 1989, Archives of dermatology.
[233] C. Baldwin,et al. A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix. , 1989, The Journal of biological chemistry.
[234] H. Kuivaniemi,et al. A single base mutation that substitutes serine for glycine 790 of the alpha 1 (III) chain of type III procollagen exposes an arginine and causes Ehlers-Danlos syndrome IV. , 1989, The Journal of biological chemistry.
[235] Hollister Dw,et al. A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta. , 1988 .
[236] P. Byers,et al. Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype. , 1988, The Journal of biological chemistry.
[237] R. Glanville,et al. Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain. , 1987, The Journal of biological chemistry.
[238] D. Prockop,et al. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta. , 1987, The Journal of biological chemistry.
[239] P. Byers,et al. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[240] R. Jaenisch,et al. Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[241] K. Okuyama,et al. Crystal and molecular structure of a collagen-like polypeptide (Pro-Pro-Gly)10. , 1981, Journal of molecular biology.
[242] I. Pastan,et al. The collagen gene: Evidence for its evolutionary assembly by amplification of a DNA segment containing an exon of 54 bp , 1980, Cell.
[243] L. Peltonen,et al. A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[244] D. Prockop,et al. Synthesis of (Pro-Hyp-Gly) n of defined molecular weights. Evidence for the stabilization of collagen triple helix by hydroxypyroline. , 1973, Biochimica et biophysica acta.
[245] J. Trimbos,et al. [Alport's syndrome (hereditary nephritis with deafness]. , 1967, Nederlands tijdschrift voor geneeskunde.
[246] F. Steven. THE CLEAVAGE OF TYROSYL PEPTIDES BY PEPSIN FROM COLLAGEN SOLUBILISED BY THE NISHIHARA TECHNIQUE. , 1965, Biochimica et biophysica acta.
[247] N. Grant,et al. Collagen solubilization by mammalian proteinases. , 1960, Archives of biochemistry and biophysics.
[248] G. N. Ramachandran,et al. Structure of Collagen , 1954, Nature.
[249] F. Kőrösy. A Modified Differential Refractometer , 1954, Nature.
[250] Shiguang Liu,et al. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[251] B. Hudson,et al. Embryo implantation triggers dynamic spatiotemporal expression of the basement membrane toolkit during uterine reprogramming. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[252] J. Zenteno,et al. Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosity , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.
[253] S. Ricard-Blum. The collagen family. , 2011, Cold Spring Harbor perspectives in biology.
[254] 宏之 清水. Humanization of autoantigen: 水疱性類天疱瘡の病態解明と新規治療法開発 , 2009 .
[255] M. Yamauchi,et al. Lysine hydroxylation and cross-linking of collagen. , 2008, Methods in molecular biology.
[256] Not Available Not Available,et al. Literature Abstracts , 2001, Pediatric Nephrology.
[257] R. Liddington,et al. Structural basis of collagen recognition by integrin alpha2beta1. , 2000, Cell.
[258] N. Noro,et al. Type IV collagen in sponges, the missing link in basement membrane ubiquity * , 1996, Biology of the cell.
[259] H. Smeets,et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. , 1994, Nature genetics.
[260] M. Gregory,et al. Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. , 1991, Genomics.
[261] M. K. Wirtz,et al. A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta. , 1988, Molecular biology & medicine.
[262] R. Jaenisch,et al. Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. , 1983, Nature.
[263] D. Lamport. The role of hydroxyproline-rich proteins in the extracellular matrix of plants. , 1974, The ... Symposium. Society for Developmental Biology. Symposium.
[264] J. Visakorpi,et al. [Hereditary renal diseases]. , 1972, Duodecim; laaketieteellinen aikakauskirja.
[265] F. O. Schmitt,et al. Action of proteolytic enzymes on tropocollagen and insoluble collagen. , 1966, Biochemistry.
[266] R. Hafter,et al. [The effect of pepsin on the structure and fiber-forming properties of collagen]. , 1963, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[267] P. Esposito,et al. Osteogenesis Imperfecta. , 1928, Proceedings of the Royal Society of Medicine.
[268] N. Joyce,et al. The FASEB Journal • Research Communication Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye , 2022 .
[269] Y. Sado,et al. J Am Soc Nephrol 15: 1466–1474, 2004 Mouse Model of X-Linked Alport Syndrome , 2022 .
[270] C. Gieger,et al. Recessive Mutations in the a 3 (VI) Collagen Gene COL6A3 Cause Early-Onset Isolated Dystonia , 2022 .